MIT Technology Review @techreview
China has five vaccine candidates from four manufacturers in phase three clinical trials, including the frontrunners from Sinopharm and Sinovac Biotech. https://t.co/QBDjVryiFJ — PolitiTweet.org
Created
Fri Dec 04 20:27:14 +0000 2020
Likes
7
Retweets
2
Source
Twitter Web App
View Raw Data
JSON DataView on Twitter
Likely Available
MIT Technology Review @techreview
China has five vaccine candidates from four manufacturers in phase three clinical trials, including the frontrunners from Sinopharm and Sinovac Biotech. https://t.co/QBDjVryiFJ — PolitiTweet.org